![]() |
市場調査レポート
商品コード
1473932
マイクロバブル/超音波造影剤の世界市場規模、シェア、成長分析、疾患領域別、用途別-産業予測、2024~2031年Global Microbubbles/Ultrasound Contrast Agents Market Size, Share, Growth Analysis, By Disease Area(cardiovascular diseases, renal diseases), By Application(molecular imaging, drug delivery) - Industry Forecast 2024-2031 |
マイクロバブル/超音波造影剤の世界市場規模、シェア、成長分析、疾患領域別、用途別-産業予測、2024~2031年 |
出版日: 2024年04月28日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
マイクロバブル/超音波造影剤の世界市場規模は、2022年に18億7,000万米ドルと評価され、2023年の19億4,000万米ドルから2031年には26億6,000万米ドルに成長し、予測期間中(2024~2031年)にCAGR 4.00%で成長する展望です。
X線下の液体や構造物の可視性を高めるために医用画像診断で使用される物質は、造影剤または造影媒体として知られ、通常X線に対して透明です。造影超音波イメージングでは、マイクロバブルは放射線学と心臓病学で血液プール剤として機能し、遺伝子治療、ドラッグデリバリー、分子イメージング、幹細胞デリバリーで広範な応用を見出しています。これらのマイクロバブルは、疾患特異的な分子マーカーと結合することによっても機能し、標的診断の手段を記載しています。マイクロバブルは、静脈注射によって循環する赤血球のような働きをし、超音波パルスの下で強いエコーを発生させ、周囲の軟組織ガスとは異なるエコー源性によって超音波の反射や後方散乱を増幅し、心エコー図にコントラストを与えます。
Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 1.87 billion in 2022 and is poised to grow from USD 1.94 billion in 2023 to USD 2.66 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
A substance used in medical imaging to enhance the visibility of fluids or structures under X-rays, known as contrast media or contrast agent, is typically transparent to X-rays. In contrast ultrasound imaging, microbubbles serve as a blood pool agent in radiology and cardiology, finding extensive application in gene therapy, drug delivery, molecular imaging, and stem cell delivery. These microbubbles can also operate by binding to disease-specific molecular markers, offering a means of targeted diagnosis. Functioning akin to red blood cells in circulation upon intravenous injection, microbubbles generate strong echoes under ultrasound pulses, providing enhanced contrast in echocardiograms by amplifying ultrasound reflection or backscattering due to their differing echogenicity from surrounding soft tissue gases.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microbubbles/Ultrasound Contrast Agents Market Segmental Analysis
Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of disease area, By application, and By Region. Whereas, Disease area is sub segmented into cardiovascular diseases, renal diseases, and others. By Application is sub segmented into the molecular imaging, drug delivery, gene therapy, and stem cells delivery. By Region is segmented on the basis of North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Drivers of the Global Microbubbles/Ultrasound Contrast Agents Market
The utilization of microbubbles and ultrasound contrast agents in molecular imaging is increasingly fueled by the rising requirement for targeted therapies and the necessity to monitor biomarker status in vascular endothelium. Over the projected period, the market for microbubbles/ultrasound contrast agents is expected to grow, propelled by advancements in ultrasound technologies, escalating demand for targeted diagnostic instruments, the inherent advantages of microbubbles/ultrasound contrast agents compared to conventional diagnostic methods, and a surge in chronic disease prevalence.
Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market
The global Microbubbles/Ultrasound Contrast Agents market faces a significant restraint due to the brief lifespan of microbubbles, hindering its growth prospects throughout the forecast period. Additionally, regulatory hurdles, limited reimbursement policies, and high manufacturing costs further impede market expansion, posing challenges to widespread adoption and innovation in ultrasound contrast agents.
Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market
In the fields of cardiology and radiology, microbubbles are employed as blood-pool agents in contrast ultrasound imaging but are increasingly acknowledged for their promise as targeted agents in molecular imaging. By incorporating ligand molecules that attach to disease-specific molecular markers, microbubbles can be tailored for functionality. This enables the monitoring of biomarker status in vascular endothelium, visualization of tumor vasculature, and imaging of inflammation, ischemia-reperfusion injury zones, and thrombi, presenting diverse clinical applications for molecular imaging utilizing microbubble-based ultrasound contrast agents.